FluiDx-AD seeks to develop a trio of complementary tests:
SalivaDx-AD: An easy-to-use, at-home saliva test for population-wide detection of individuals at risk of developing AD in its prodromal stages.
PlasmaDx-AD: A minimally invasive and cost-effective blood test for high-precision confirmatory diagnosis for individuals with suspected AD.
BloodCellDx-AD: A minimally invasive, whole blood ex vivo test system to evaluate the risk of amyloid-related imaging abnormalities (ARIA), to support patient eligibility assessments and ARIA monitoring for anti-amyloid therapies
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://linktr.ee/FluiDx_AD
- Keywords
- Lurtis AI.
Fluidx-Ad Questions
Fluidx-Ad's website is https://linktr.ee/FluiDx_AD
Fluidx-Ad's LinkedIn profile is https://www.linkedin.com/company/fluidx-ad
Fluidx-Ad's industry is
Biotechnology Research
Fluidx-Ad's top competitors are
Jefferson Wells Norge,
Horizon Group Europe,
Gsk,
Horizon Europe,
The Ai-Mind Project,
Council Of Health Insurance,
Lurtis Ai,
Pre Diagnostics As,
European Commission.
Fluidx-Ad's categories are Biotechnology Research
